Items tagged with Vaccines
Aeras launches AerasSHARE Biorepository to help advance TB vaccine research (post)
Rockville, MD, September 28, 2016 –Aeras, a nonprofit research and development organization dedicated to the development of new TB vaccines, has launched the AerasSHARE Biorepository, a new website to allow researchers from other organizations to access specimens and datasets that were collected by Aeras and its research partners in an effort to facilitate state-of-the-art TB vaccine related science and promote world-wide collaboration among TB vaccine researchers.
Status of vaccine research and development of TB vaccines (post)
Abstract
How the tuberculosis vaccine may protect against other diseases (post)
The tuberculosis vaccine is well known to help protect against other infectious diseases, as well as cancer, but the exact mechanisms have not been clear. A study published December 6 in Cell Reports now shows that the broad-spectrum effects of the Bacillus Calmette-Guerin (BCG) vaccine--the most widely used vaccine in the world--could be mediated by metabolic and epigenetic changes in white blood cells called monocytes through a process called trained immunity. This discovery could pave the way for strategies that combine immunological and metabolic stimulation to boost the effectiveness of vaccines and anti-cancer therapies.
Scientists accelerate immune response to TB in mice (post)
New research findings provide insight into the immune system pathways that may be key to developing an effective tuberculosis (TB) vaccine. The study, published in the journal Nature Communications, was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Cleverly designed TB vaccine shows promise in mice (post)
Washington, DC - January 13, 2017 - A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the disease, and the large annual death toll, a successful vaccine could be a huge benefit to public health--especially in low- and middle income countries. The research is published January 13th in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.
Plant-based ingredient could lead to improved TB vaccine (post)
The tuberculosis (TB) vaccine hasn’t changed much since it was first used on humans almost a century ago, yet the disease is still prevalent in Canada’s aboriginal communities and in developing countries.
Tracking TB vaccination policies and practices through space and time (post)
The 2nd Edition of the BCG World Atlas provides user friendly, open access, and easy to access data on the current TB vaccine, and provides the clinician, researcher, and public health practitioner alike with resources and information necessary to interpret current and novel TB diagnostics and conduct fruitful research on novel vaccines.
TB vaccine safe for teens with Schistosoma parasite (post)
Of the millions of people at risk for contracting tuberculosis each year, many are already infected with helminths, parasitic worms including Schistosoma flatworms. In some cases, parasite infections can impair the ability of an immunization to work. But adolescents infected with Schistosoma mansoni respond as well as uninfected teens do to a candidate booster tuberculosis vaccine, according to a new study in PLOS Neglected Tropical Diseases.
TB vaccine passes important milestone (post)
Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
MTBVAC from discovery to clinical trials in TB-endemic countries (post)
Abstract
Page 7 of 32 · Total posts: 0
←First 6 7 8 Last→